Ulipristal Acetate (UPA)

Showing 1-8 of 25 results

Clinical scenario: Placing an IUD after unprotected sex

What providers need to know about placing a levonorgestrel intrauterine device (LNG-IUD) after unprotected sex

Clinical scenario: Emergency contraception (EC) for transgender or gender nonbinary (TGNB) patients

What providers need to know about offering emergency contraception (EC) to transgender and gender nonbinary (TGNB) patients

Research roundup: March 2025 edition

Partner treatment for BV, pain and bleeding experiences during first-trimester abortion, interest in Rh testing and treatment for telehealth medication abortion.

Research roundup: February 2025 edition

Double dosing UPA for EC not needed for BMI > 30, postpartum implant placement and milk supply, mifepristone to increase efficacy of medication management of EPL.

Research roundup: August 2024 edition

U.S. MEC and U.S. SPR, standard dosing of UPA EC for people of all body sizes, birth control information on TikTok, and safety of medication abortion without screening ultrasound.

Health care providers and access to EC

How health care providers can support improved access to this important birth control method.

Research roundup: May 2024 edition

Patient characteristics of IUD placement under sedation, two studies on EC efficacy, substance use and anxiety among patients seeking an abortion, and genital herpes prevalence.

Research roundup: February 2024 edition

Abortion information on TikTok, doxy-PEP effectiveness in cis-gendered women; new data on UPA-EC and implant insertion; and a survey of pain with IUD insertion.
  • Previous
  • 1(current)
  • 2
  • 3
  • 4
  • Next